Up | AC
Home Page
Food and
Drug Administration
Peripheral
and Central Nervous System Drugs Advisory Committee
January 07-08, 2009
BRIEFING INFORMATION
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material (pdf)
Ovation
Pharmaceuticals, Inc
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily agree with the
sponsor's statements. FDA has not made a final determination about the safety
or effectiveness of the product described in this document.
Briefing Material (pdf)